Eisai Pulls Another Leqembi Growth Lever With First Subcutaneous Approval

List Price Is $375 Per Dose, $19,500 Annually

 
• By Mandy Jackson
  
Subcutaneous Leqembi could ease the treatment burden for Alzheimer's patients and health care providers (Shutterstock)

More from Neurological

More from Therapy Areas